References
- O’Neil B. H., Tepper J. E. Current options for the management of rectal cancer. Curr Treat Options Oncol, 2007, 8: 331–8.
- Borschitz T., Wachtlin D., Möhler M., Schmidberger H., Junginger T. Neo-adjuvant chemoradiation and local excision for T2–3 rectal cancer. Ann Surg Oncol, 2008, 15: 712–20.
- Rosenberg R., Nekarda H., Zimmermann F., Becker K., Lordick F., Hofler H., Molls M., Siewert JR. Histopathological response after pre-operative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol, 2008, 97: 8–13.
- Gosens M. J., Klaassen R. A., Tan-Go I., Rutten H. J., Martijn H., van den Brule A. J., Nieuwenhuijzen G. A., van Krieken J. H., Nagtegaal I. D. Circumferential margin involvement is the crucial prognostic factor after multi-modality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res, 2007, 13: 6617–23.
- Chang F., Deere H., Mahadeva U., George S. Histopathologic examination and reporting of oesophageal carcinomas following pre-operative neo-adjuvant therapy: practical guidelines and current issues. Am J Clin Pathol, 2008, 129: 252–62.
- Galindo Gallego M., Fernández Aceñero M. J., Sanz Ortega J., Aljama A., Balibrea Cantero J. L. The prognostic influence of p53 nuclear expression in colorectal carcinoma. Dis Colon and Rectum, 2000, 43: 971–975.
- Larsen S. G., Wiig J. N., Dueland S., Giercksky K. E. Prognostic factors after pre-operative irradiation and surgery for locally advanced rectal cancer. Eur J Surg Oncol, 2008, 34: 410–7.
- Glynne-Jones R., Wallace M., Livingstone J. I., Meyrick- Thomas J. Complete clinical response after pre-operative chemoradiation in rectal cancer: is a “wait and see” policy justified ? Dis Colon Rectum, 2008, 51: 10–9.
- Kuo L. J., Liu M. C., Jian J. J., Horng C. F., Cheng T. I., Chen C. M., Fang W. T., Chung Y. L. Is final TNM staging a predictor for survival in locally advanced rectal cancer after pre-operative chemoradiation therapy ? Ann Surg Oncol, 2007, 14: 2766–72.
- Das P., Skibber J. M., Rodriguez-Bigas M. A., Feig B. W., Chang G. J., Wolff R. A., Eng C., Krishnan S., Janjan N. A., Crane C. H. Predictors of tumour response and down-staging in patients who receive pre-operative chemoradiation for rectal cancer. Cancer, 2007, 109: 1750–5.
- Perez R. O., Habr-Gama A., dos Santos R. M., Proscurshim I., Campos F. G., Rawet V., Kiss D., Cecconello I. Peritumoral inflammatory infiltrate is not a prognostic factor in distal rectal cancer following neo-adjuvant chemoradiation therapy. J Gastro-intest Surg, 2007, 11: 1534–40.
- Shivnani A. T., Small W. Jr., Stryker S. J., Kiel K. D., Lim S., Halverson A. L., Talamonti M. S. Pre-operative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg, 2007, 193: 389–93.
- Szynglarewicz B., Matkowski R., Maciejczyk A., Kasprzak P., Forgacz J., Pudelko M. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient’s age and long-term outcome. J Gastro-intestin Liver Dis, 2008, 17: 49–52.
- Lin L. C., Lee H. H., Hwang W. S., Li C. F., Huang C. T., Que J., Lin K. L., Lin F. C., Lu C. L. p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neo-adjuvant therapy. Surg Oncol, 2006, 15: 211–6.